GDTC logo

GDTC Stock Overview

Profile

Full Name:

CytoMed Therapeutics Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Singapore

IPO:

April 14, 2023

Indexes:

Not included

Website:

http://w2.cytomed.sg

Description:

GDTC (CytoMed Therapeutics Limited) focuses on developing innovative cell therapies for cancer treatment. The company leverages advanced technology to enhance immune responses against tumors, aiming to improve patient outcomes and provide effective solutions in the field of oncology.

Key Details

Price

$2.80

Market Cap

$32.31 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.29(-39.82% YoY)

PE Ratio

-

Annual ROE

-36.14%

Annual Debt To Equity

0.04

Beta

0.30

Events Calendar

Earnings

Next earnings date:

Apr 29, 2025

Recent quarterly earnings:

Apr 29, 2024

Recent annual earnings:

Apr 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 10, 24 Benchmark
Speculative Buy
Jun 11, 24 Benchmark
Speculative Buy
Dec 4, 23 Benchmark
Speculative Buy
Jul 21, 23 Benchmark
Speculative Buy

Screeners with GDTC included

Growing Shares Outstanding
Best performing stocks last 3 months
Stocks above SMA 50
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks with low beta
Stocks above SMA 200
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.80
GDTC price is $2.80

Price All-time High

$5.64
GDTC price is currently -50.35% below its historical high of $5.64

Price Analysts Target

-
GDTC price consensus analysts' forecast is unknown

Price Most Recent Change

+0.36%
GDTC price was up +0.36% on Feb 27, 2025

Price YTD Change

-17.4%
GDTC price is down -17.4% since January 1st

Price 3-Year Change

-
GDTC price 3-year change is unknown

Market cap

Market Cap

$32.31 M
GDTC market capitalization is $32.31 million

Market Cap 3-Year Change

-
GDTC market capitalization 3-year change is unknown

Market Cap All-time High

$65.03 M
GDTC market capitalization is currently -50.31% below its historical high of $65.03 million

Market Cap Sector Rank

30.65%
GDTC market capitalization is higher than 30.65% of companies in Healthcare sector

Technical

Beta

0.30
GDTC beta is 0.30

200-day SMA

$2.18
GDTC price is currently +28.32% above its 200-day simple moving average

14-day RSI

55.09
GDTC 14-day relative strength index is 55.09

30-day Relative Volume

0.37
GDTC 30-day relative volume is 0.37

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
GDTC annual revenue value is unknown

Annual Revenue Analysts Estimate

$571.00 K
GDTC annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
GDTC annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
GDTC annual revenue is unknown

Profit

Annual Gross Profit

-
GDTC annual gross profit value is unknown

Annual Gross Margin

-
GDTC annual gross profit margin value is unknown

Annual Operating Profit

-$2.86 M
GDTC annual operating income is -$2.86 million

Annual Operating Margin

-
GDTC annual operating profit margin value is unknown

Annual Net Income

-$3.08 M
GDTC annual net profit is -$3.08 million

Annual Net Margin

-
GDTC annual net profit margin value is unknown

EPS

Annual EPS

-$0.29
GDTC annual earnings per share is -$0.29

Annual EPS Analysts Estimate

-$0.15
GDTC annual earnings per share is currently +93.60% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-39.82%
GDTC annual earnings per share is down -39.82% year-on-year

Annual EPS Sector Rank

76.21%
GDTC annual earnings per share is higher than 76.21% of companies in Healthcare sector

ROA & ROE

Annual ROA

-32.86%
GDTC annual return on assets is -32.86%

Annual ROE

-36.14%
GDTC annual return on equity is -36.14%

EBIT & EBITDA

Annual EBIT

-$3.04 M
GDTC annual earnings before interest & taxes is -$3.04 million

Annual EBITDA

-$2.75 M
GDTC annual EBITDA is -$2.75 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
GDTC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
GDTC price to earnings ratio is unknown

PB Ratio

PB Ratio

4.31
GDTC price to book ratio is 4.31

PB Ratio Sector Rank

78.1%
GDTC price to book ratio is higher than 78.1% of companies in Healthcare sector

PS Ratio

PS Ratio

-
GDTC price to sales ratio value is unknown

PS Ratio Sector Rank

-
GDTC price to sales ratio is unknown

Enterprise value

Enterprise Value

$27.86 M
GDTC enterprise value is $27.86 million

Enterprise Value Sector Rank

33%
GDTC enterprise value is higher than 33% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GDTC EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
GDTC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

14.08
GDTC annual current ratio is 14.08

Annual Quick Ratio

-
GDTC annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.04
GDTC annual debt to equity ratio is 0.04

Annual Interest Coverage Ratio

-79.54
GDTC annual interest coverage ratio is -79.54

Risk & Stability

Piotroski F-Score

-
GDTC piotroski f-score value is unknown

Altman Z-Score

-
GDTC altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$9.36 M
GDTC annual total assets is $9.36 million

Annual Non Current Assets

$1.72 M
GDTC annual long term assets is $1.72 million

Annual Current Assets

$7.64 M
GDTC annual total current assets is $7.64 million

Annual Cash & Cash Equivalents

$6.81 M
GDTC annual cash & cash equivalents is $6.81 million

Equity

Annual Book Value

$8.51 M
GDTC annual book value is $8.51 million

Annual Working Capital

$7.10 M
GDTC annual working capital is $7.10 million

Liabilities

Annual Total Liabilities

$851.50 K
GDTC annual total liabilities is $851.50 thousand

Annual Total Long Term Liabilities

$308.70 K
GDTC annual total long term liabilities is $308.70 thousand

Annual Current Liabilities

$542.80 K
GDTC annual total current liabilities is $542.80 thousand

Annual Accounts Payable

$18.60 K
GDTC annual accounts payable is $18.60 thousand

Debt

Annual Total Debt

$339.20 K
GDTC annual total debt is $339.20 thousand

Annual Total Debt 1-Year Change

-89.22%
GDTC annual total debt is down -89.22% year-on-year

Annual Long Term Debt

$308.70 K
GDTC annual long term debt is $308.70 thousand

Annual Short Term Debt

$30.50 K
GDTC annual short term debt is $30.50 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.86 M
GDTC annual total expenses is $2.86 million

Annual Operating Expenses

$2.86 M
GDTC annual total operating expenses is $2.86 million

Annual Cost Of Goods Sold

-
GDTC annual cost of goods sold value is unknown

Annual SGA

$956.10 K
GDTC annual SGA is $956.10 thousand

Annual D&A

$283.80 K
GDTC annual depreciation & amortization is $283.80 thousand

Annual Interest Expense

$38.20 K
GDTC annual interest expense is $38.20 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$2.56 M
GDTC annual cash flow from operations is -$2.56 million

Annual CFO 1-Year Change

-151.88%
GDTC annual cash flow from operations is down -151.88% year-on-year

Annual CFI

-$2.11 M
GDTC annual cash flow from investing activities is -$2.11 million

Annual CFI 1-Year Change

-513.4%
GDTC annual cash flow from investing activities is down -513.4% year-on-year

Annual CFF

$8.13 M
GDTC annual cash flow from financing activities is $8.13 million

Annual CFF 1-Year Change

+1056.64%
GDTC annual cash flow from financing activities is up +1056.64% year-on-year

Free CashFlow

Annual FCF

-$2.60 M
GDTC annual free cash flow is -$2.60 million

Annual FCF 1-Year Change

-91.33%
GDTC annual free cash flow is down -91.33% year-on-year

CAPEX

Annual CAPEX

-
GDTC annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
GDTC annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

ELEV logo
Elevation Oncology (ELEV)
SNYR logo
Synergy CHC (SNYR)
MOVE logo
Movano (MOVE)
ANTX logo
AN2 Therapeutics (ANTX)
ESLA logo
Estrella Immunopharma (ESLA)
PASG logo
Passage Bio (PASG)
INTS logo
Intensity Therapeutics (INTS)
NMTC logo
NeuroOne Medical Technologies (NMTC)
PIII logo
P3 Health Partners (PIII)

FAQ

  • What is the ticker symbol for CytoMed Therapeutics Limited?
  • Does CytoMed Therapeutics Limited pay dividends?
  • What sector is CytoMed Therapeutics Limited in?
  • What industry is CytoMed Therapeutics Limited in?
  • What country is CytoMed Therapeutics Limited based in?
  • When did CytoMed Therapeutics Limited go public?
  • Is CytoMed Therapeutics Limited in the S&P 500?
  • Is CytoMed Therapeutics Limited in the NASDAQ 100?
  • Is CytoMed Therapeutics Limited in the Dow Jones?
  • When was CytoMed Therapeutics Limited's last earnings report?
  • When does CytoMed Therapeutics Limited report earnings?

What is the ticker symbol for CytoMed Therapeutics Limited?

The ticker symbol for CytoMed Therapeutics Limited is NASDAQ:GDTC

Does CytoMed Therapeutics Limited pay dividends?

No, CytoMed Therapeutics Limited does not pay dividends

What sector is CytoMed Therapeutics Limited in?

CytoMed Therapeutics Limited is in the Healthcare sector

What industry is CytoMed Therapeutics Limited in?

CytoMed Therapeutics Limited is in the Biotechnology industry

What country is CytoMed Therapeutics Limited based in?

CytoMed Therapeutics Limited is headquartered in Singapore

When did CytoMed Therapeutics Limited go public?

CytoMed Therapeutics Limited's initial public offering (IPO) was on April 14, 2023

Is CytoMed Therapeutics Limited in the S&P 500?

No, CytoMed Therapeutics Limited is not included in the S&P 500 index

Is CytoMed Therapeutics Limited in the NASDAQ 100?

No, CytoMed Therapeutics Limited is not included in the NASDAQ 100 index

Is CytoMed Therapeutics Limited in the Dow Jones?

No, CytoMed Therapeutics Limited is not included in the Dow Jones index

When was CytoMed Therapeutics Limited's last earnings report?

CytoMed Therapeutics Limited's most recent earnings report was on Apr 29, 2024

When does CytoMed Therapeutics Limited report earnings?

The next expected earnings date for CytoMed Therapeutics Limited is Apr 29, 2025